Chemistry:4-APB

From HandWiki

4-(2-Aminopropyl)benzofuran (4-APB) is a monoamine releasing agent and novel designer drug of the benzofuran family.[1][2][3][4][5] It acts as a serotonin–norepinephrine–dopamine releasing agent (SNDRA).[5][4] The drug was first detected, in Europe, by 2011.[1]

See also

References

  1. 1.0 1.1 "Europol 2011 Annual Report on the implementation of Council Decision 2005/387/JHA". 23 October 2018. https://www.europol.europa.eu/publication-events/publications/emcdda-europol-2011-annual-report-implementation-of-council-decision-2005/387/jha. 
  2. "Identification of (2-aminopropyl)benzofuran (APB) phenyl ring positional isomers in internet purchased products". Drug Test Anal 5 (4): 270–276. April 2013. doi:10.1002/dta.1451. PMID 23349125. 
  3. "The characterization of 6-(2-aminopropyl) benzofuran and differentiation from its 4-, 5-, and 7-positional analogues.". Microgram Journal 9 (2): 61–74. 2012. https://www.dea.gov/sites/default/files/pr/microgram-journals/2012/mj9_61-74.pdf. 
  4. 4.0 4.1 "Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances". Handb Exp Pharmacol. Handbook of Experimental Pharmacology 252: 143–164. 2018. doi:10.1007/164_2018_113. ISBN 978-3-030-10560-0. PMID 29633178. 
  5. 5.0 5.1 "Pharmacological profile of novel psychoactive benzofurans". Br J Pharmacol 172 (13): 3412–3425. July 2015. doi:10.1111/bph.13128. PMID 25765500.